Page last updated: 2024-11-05

tilorone and Pulmonary Fibrosis

tilorone has been researched along with Pulmonary Fibrosis in 1 studies

Tilorone: An antiviral agent used as its hydrochloride. It is the first recognized synthetic, low-molecular-weight compound that is an orally active interferon inducer, and is also reported to have antineoplastic and anti-inflammatory actions.
tilorone : A member of the class of fluoren-9-ones that is 9H-fluoren-9-one which is substituted by a 2-(diethylamino)ethoxy group at positions 2 and 7. It is an interferon inducer and a selective alpha7 nicotinic acetylcholine receptor (alpha7 nAChR) agonist. Its hydrochloride salt is used as an antiviral drug.

Pulmonary Fibrosis: A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vartiainen, V1
Raula, J1
Bimbo, LM1
Viinamäki, J1
Backman, JT1
Ugur, N1
Kauppinen, E1
Sutinen, E1
Joensuu, E1
Koli, K1
Myllärniemi, M1

Other Studies

1 other study available for tilorone and Pulmonary Fibrosis

ArticleYear
Pulmonary administration of a dry powder formulation of the antifibrotic drug tilorone reduces silica-induced lung fibrosis in mice.
    International journal of pharmaceutics, 2018, Jun-10, Volume: 544, Issue:1

    Topics: Administration, Inhalation; Animals; Cell Line; Dry Powder Inhalers; Humans; Leucine; Lung; Male; Mi

2018